Low molecular weight cleaved form of cyclin E, a powerful independent predictor of survival in women with progressed breast cancer, was shown to interact with ACLY and promote aberrant lipid metabolism pathways in breast cancer tumorigenesis [154]. Here, CCNE1 is linked to breast cancer.